• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

ARIA side effects surface in 40% of patients on Biogen's Alzheimer's drug Aduhelm: JAMA | FiercePhar













No way, just listen to marketing, it’s sales fault, not anyone else’s, definitely can’t be the AEs, media, cost, lack of coverage, or anything else causing issues. Has to be sales fault.